The Molecular Imaging Program at Stanford (MIPS) was established as an inter-disciplinary program to bring together scientists and physicians who share a common interest in developing and using state-of-the-art imaging technology and developing molecular imaging assays for studying intact biological systems. A multimodality approach using imaging technologies such as positron emission tomography (PET), single photon emission computed tomography (SPECT), digital autoradiography, magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), optical bioluminescence, optical fluorescence, and ultrasound are all technologies under active development and investigation. The goals of the program are to fundamentally change how biological research is performed with cells in their intact environment in living subjects and to develop new ways to diagnose diseases and monitor therapies in patients. Areas of active investigation are cancer research, microbiology/immunology, developmental biology and pharmacology.
Sanjiv Sam Gambhir M.D., Ph.D.
- Virginia & D.K. Ludwig Professor of Cancer Research
- Chair, Department of Radiology
- Professor by courtesy, Departments of Bioengineering and Materials Science & Engineering
- Director, Molecular Imaging Program at Stanford
- Director, Canary Center at Stanford for Cancer Early Detection
Christopher Contag, Ph.D.
- Associate Chief (Research), Division of Neonatal and Developmental Medicine
- Co-Director, Molecular Imaging Program at Stanford
- Director, Stanford Center for Innovation in in vivo Imaging (SCI3)
- Professor, Pediatrics, Microbiology & Immunology, and Radiology
